Definitive Contract 75A50123C00043
Award Date
8/3/23
Potential Completion Date
10/3/24
Potential Value
$213K
Awardee
Satio Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $749,000.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to In Diagnostics, Inc. to develop endpoint and kinetic measurement capabilities on a low-cost, disposable spectrophotometer platform. The contract does not have a set-aside designation and is scheduled for completion by June 30, 2025. The awardee, In Diagnostics, Inc., is a for-profit organization located in Carlsbad, California.
<p>This is a $12,606,489.57 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to AD Astra Diagnostics, Inc. for the research and development of a CLIA-waived ubiquitous early sepsis detection and severity assessment system for use in ambulance, pre-hospital, and post-discharge settings. The contract has an ultimate completion date of December 15, 2027 and does not have a set-aside designation.</p>
This federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), is for the procurement of Ebola virus antibody and diagnostic tests to detect the virus in cadavers. The $2,222,900.00 firm fixed-price purchase order was awarded to OraSure Technologies Inc., a for-profit manufacturer of medical diagnostic products, on June 22, 2022. The contract has an ultimate completion date...
<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Boston Bioscience Inc. on September 27, 2012. The contract, valued at $35,705.00, is for the delivery of EBOLA GP (Z) CARBOXYL TERMINUS ACID PEPTIDES, 15 AMINO ACIDS IN LENGTH. The contract has a completion date of October 3, 2012 and does not utilize a set-aside designation.</p>
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract worth $248,887.50 to Boston Bioscience Inc., a for-profit organization, for the synthesis of COVID-19 related proteins. The contract was awarded on a sole-source basis, without a set-aside, to support the Vaccine Research Center's efforts in analyzing immune responses to SARS-CoV-2 infection and vaccination. The...
This is a $468,104.64 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a small disadvantaged business based in San Francisco, California. The contract is for research and development related to the clinical validation of an at-home, deep-learning based sepsis monitoring system. This contract was awarded under ASPR's Biomedical Advanced Research and Development...
<p>The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Definitive Contract to 98Point6 Inc., a for-profit organization, for comprehensive infectious disease interdiction services. The contract, valued at $257,670.00, does not have a set-aside designation and was awarded on August 6, 2019, with a completion date of February 5, 2021. The place of performance is Seattle, Washington.</p>
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This contract was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services, to Meso Scale Diagnostics LLC, a small business provider of assay development, testing equipment, and immunoassays. The contract, valued at $23,234,896, is for the acquisition of assays to support COVID-19 vaccine development efforts, in response to a Broad Agency Announcement (BAA) issued by the agency. The contract is a...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...